摘要
目的探讨康莱特在妇科恶性肿瘤化疗中的疗效。方法将106例妇科恶性肿瘤患者按照数字表法随机分为两组,对照组53例给予单纯化疗,试验组53例给予化疗加康莱特治疗。比较两组患者临床疗效、白细胞计数及生活质量评分的差异。结果试验组患者临床缓解率为30.2%,稍高于对照组(20.8%),差异未见统计学意义(P>0.05)。治疗后试验组患者白细胞计数降低,但其显著高于同期对照组,差异有统计学意义(P<0.05)。治疗后试验组患者KPS评分降低,但其显著高于同期对照组,差异有统计学意义(P<0.05)。结论康莱特在妇科恶性肿瘤化疗中效果显著,其具有较高的缓解率,骨髓抑制轻、生活质量高,值得临床选择。
Objective To investigate the curative effect of Kanglaite injection combined with chemotherapy on malignant gynecological tumor. Methods A total of 106 patients with gynecological malignant tumor were randomly divided into two groups according to the digital table,with 53 patients in each group. The patients of control group were treated by chemotherapy,while the patients in the experiment group were treated by chemotherapy combined with Kanglaite injection. The clinical curative effects,white blood cell counts and quality of life scores were compared. Results The clinical remission rate of patients in experiment group was 30. 2%,which was slightly higher than that in the control group( 20. 8%),there was no significant difference( P 0. 05). The number of white blood cells reduced after treatment in the experiment groups,which was significantly higher than that of the control group at the same period,there was significant difference( P 0. 05). After treatment,the KPS of patients in the experiment group decreased,which was significantly higher than that of the control group at the same period,there was significant difference( P 0. 05). Conclusion Kanglaite has remarkable effect on the chemotherapy of gynecology malignant tumor. Kanglaite has higher remission rate,lighter bone marrow suppression,high quality of life,and it is worthy clinical application.
出处
《临床医学》
CAS
2017年第1期38-39,共2页
Clinical Medicine
关键词
康莱特
妇科恶性肿瘤
化疗
疗效
Kanglaite
Gynecological malignant tumor
Chemotherapy
Effect